Biohal's mission is to create a universally available preventive medicine platform that runs on blockchain with liquid biopsy protocol. By joining hands with PROTEO, the first liquid biopsy research partner, Biohal can detect cancer and alzheimers at early stages. With minimally invasive markers, Biohal's test accuracy remains at 99%.

3.7
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closes 10 months, 1 week from now

Pre-Sale 09/18/2018 midnight - 10/15/2018 midnight
Token Sale 11/15/2018 midnight - 11/30/2019 midnight
Country Switzerland
D
Dr. Yoshitaka Fukuzawa
MEDICAL ADVISOR
Advisors
Y
Yuki Hasegawa
CEO AND FOUNDER
Advisor of this ICO only
D
Dr. Kensho Yorozu
CTO/MEDICAL TECHNICAL ADVISOR
Advisor of this ICO only
3.7
See rating distribution
ICO rating reflects the amount of information available about a project and does not indicate its quality. Therefore, ICO rating must not be taken as investment advice

Closes 10 months, 1 week from now

Pre-Sale 09/18/2018 midnight - 10/15/2018 midnight
Token Sale 11/15/2018 midnight - 11/30/2019 midnight
Country Switzerland

Financial information

Platform Ethereum
Whitelist/KYC Whitelist & KYC
Token price 0.1 USD

Interest

Alexa rank 8,104,027 th
Twitter followers 127
Promotional video views 39
Similar icos
Disclaimer

TrackICO does not encourage investing in any ICOs published on the platform. Make sure to do your own thorough research before putting money into Initial Coin Offerings. All content on TrackICO is meant to be used for information purposes only, and should not be taken as financial or investment advice.